A CORONAVIRUS vaccine may be distributed in all 50 states as soon as late October or early November, the Centers for Disease Control and Prevention revealed.
On Wednesday, the New York Times reported that the CDC has notified public health officials in all 50 states and New York, Chicago, Philadelphia, Houston and San Antonio to prepare to distribute a vaccine to health-care workers and high-risk groups.
A vaccine in late October or early November could mean it arrives before election day on Nov. 3.
The CDC provided planning scenarios for two coronavirus vaccines given that supplies "may be constrained" during the distribution.
CDC Director Dr. Robert Redfield asked states to waive requirements that could get in the way of distributing vaccines and set up distribution sites before Nov. 1.
Talks of a vaccine being available to certain groups including high-risk or health-care workers before clinical trials are done has been discussed by Dr. Anthony Fauci and FDA head, Dr. Stephen Hahn.
While the scenario documents propose distributing the vaccine as early as late October, it does not guarantee it will be available.
"The COVID-19 vaccine landscape is evolving and uncertain, and these scenarios may evolve as more information is available," one of the documents reads.
Saskia Popescu, an infection prevention epidemiologist told The New York Times that the timeline could be seen as a "push for a pre-election vaccine."
"This timeline of the initial deployment at the end of October is deeply worrisome for the politicization of public health and the potential safety ramifications," Popescu said.
If a vaccine is available by early November, the CDC cautions that it would be available in limited doses.
According to the scenarios, one of the vaccines, Vaccine A, seems to match Pfizer's, could have two million doses ready within the time frame and tens of millions of doses of each vaccine by the end of 2020.
In the documents released, the CDC said the vaccine would be free for patients but providers might not get reimbursements for administrative costs in emergency cases.
Several vaccines are currently in Phase 3 of their trials and are being developed by Moderna and Pfizer.
Over $10 billion has been committed to developing the vaccine however expenses for distributing the vaccines has not be specified.
Source: Read Full Article